Background: Barbiturates are reported to reduce brain oxidative metabo
lism and brain free fatty acid release during ischemia by mechanisms t
hat are as yet unclear. To elucidate their action on brain lipid metab
olism, an in vivo method was used to quantify the effect of pentobarbi
tal on the incorporation of radiolabeled palmitic acid from blood into
lipids of the rat brain. Methods: [9,10-H-3]-Palmitate was infused in
travenously in an awake rat or in a rat lightly anesthetized or made c
omatose by pentobarbital. Twenty minutes after infusion was begun, the
rat was killed and non-(H2O)-H-3 radioactivity in individual brain li
pid compartments was determined. Incorporation coefficients (k) were
calculated by dividing the lipid compartment radioactivities by the in
tegrated plasma radioactivity to 20 min. Results: Net brain k for [9,
10-H-3]-palmitate was reduced by 36-40% in pentobarbital-anesthetized
rats. This reduction was unrelated to depth of anesthesia or to the pr
esence of hypercapnia and acidosis, because breathing 7.5% CO2 had no
effect on k in awake rats. Anesthesia reduced radiolabel incorporatio
n into phospholipids by 46-53% and into neutral lipids by 20-26% but d
id not change the distribution of radiolabel among phospholipid or neu
tral lipid classes.Conclusions: Pentobarbital has a profound effect on
brain lipid metabolism. It reduces incorporation of plasma palmitate
into brain, more so into phospholipids than into neutral lipids, indep
endently of changes in cerebral blood flow. Reduced incorporation like
ly reflects reduced turnover of palmitate within brain lipids (mainly
phosphatidylcholine), consistent with evidence that barbiturates also
reduce release of free fatty acids during brain ischemia.